3 Jefferies Group Oruka Therapeutics Trades
Jefferies Group acquired 65k Oruka Therapeutics shares worth $973k. That's 0.02% of their equity portfolio (460th largest holding). The investor owns 2.79% of the outstanding Oruka Therapeutics stock. Jefferies Group started to build up the position in Oruka Therapeutics in Q4 2024 and continued to invest until Q1 2025. Since then they sold 340k shares.
Avg closing price
Price range
Sold 84.0% shares (-340k shares)
Q2 2025
Avg closing price
$12.01
Price range
$10.90
-
$13.19
Increased shares by 15.7% (+55k shares)
Q1 2025
Avg closing price
-
Price range
-
-
-
New holding (+350k shares)
Q4 2024
Avg closing price
-
Price range
-
-
-
News about Oruka Therapeutics, Inc. and Jefferies Group
ARCA biopharma Inc Shares Approach 52-Week Low - Market Mover
ARCA biopharma Inc (ABIO) shares closed today at 1.5% above its 52 week low of $2.01, giving the company a market cap of $29M. The stock is currently down 5...